EPM speaks to key players in the pharma industry to find out what will be trending in 2020.
2020
Biosimilars
The biosimilars market is expected to contribute to cost savings in the US pharmaceutical industry this year, according to a new report by GlobalData.
The report predicts that biosimilars will gain a strong foothold in the US due to the expiration of a number of biological patents. In particular, pharmaceutical companies will be looking to build on the success of seen by Amgen and Pfizer’s biosimilar strategies.